about
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression.Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner.MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinones.Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potency.A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiationMitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblastsBiallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma.Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib.A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposideA Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells
P50
Q36140846-D305B5D9-9759-4375-BF48-917442ACE983Q36733204-79EFD167-2A5F-4D12-B28E-0DF73CC8B025Q39209717-52BC92BB-02D9-483C-8B49-14AA370DB8E5Q39482583-A172920E-E955-4036-B6EE-627971ABC0E3Q39594041-185EBF89-CCC6-41C4-9DE8-A916ECD9B998Q40313496-C45338FA-68E1-44CC-87F8-90CE2CDE2043Q40854245-37468FAB-8CEB-4F63-BFA9-4B0766C51F2DQ40890713-60BFDBA1-5077-493F-8523-036B14F636FBQ47793645-62432AFC-E0EA-483B-8A5B-AD07F22A1DD3Q50116993-2BFBCA36-69BF-4D98-AFAE-145490C01097Q52312711-C696427C-F61C-4DEA-B43C-35ED8E7206CBQ52352234-CEE6AE6F-B5AE-4E0A-BF6E-A2AC83F8C7EAQ55270235-8B93F224-3062-460A-9493-1F28560A364CQ84453578-A79C9A60-E11A-486D-903A-9691CD5DAFAEQ91710887-8BF18FAC-62F8-4BDE-8A89-F80A9722D59E
P50
description
researcher, ORCID id # 0000-0002-7019-3173
@en
wetenschapper
@nl
name
Catherine Drummond
@ast
Catherine Drummond
@en
Catherine Drummond
@es
Catherine Drummond
@nl
type
label
Catherine Drummond
@ast
Catherine Drummond
@en
Catherine Drummond
@es
Catherine Drummond
@nl
prefLabel
Catherine Drummond
@ast
Catherine Drummond
@en
Catherine Drummond
@es
Catherine Drummond
@nl
P106
P21
P31
P496
0000-0002-7019-3173